CN1241570C - 胆汁分泌促进组合物 - Google Patents

胆汁分泌促进组合物 Download PDF

Info

Publication number
CN1241570C
CN1241570C CNB018105831A CN01810583A CN1241570C CN 1241570 C CN1241570 C CN 1241570C CN B018105831 A CNB018105831 A CN B018105831A CN 01810583 A CN01810583 A CN 01810583A CN 1241570 C CN1241570 C CN 1241570C
Authority
CN
China
Prior art keywords
ketone
purposes
prostaglandin compound
compound
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018105831A
Other languages
English (en)
Chinese (zh)
Other versions
CN1450899A (zh
Inventor
上野隆司
末松诚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Publication of CN1450899A publication Critical patent/CN1450899A/zh
Application granted granted Critical
Publication of CN1241570C publication Critical patent/CN1241570C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB018105831A 2000-04-06 2001-04-05 胆汁分泌促进组合物 Expired - Fee Related CN1241570C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19489400P 2000-04-06 2000-04-06
US60/194,894 2000-04-06

Publications (2)

Publication Number Publication Date
CN1450899A CN1450899A (zh) 2003-10-22
CN1241570C true CN1241570C (zh) 2006-02-15

Family

ID=22719290

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018105831A Expired - Fee Related CN1241570C (zh) 2000-04-06 2001-04-05 胆汁分泌促进组合物

Country Status (15)

Country Link
US (2) US6469062B2 (enExample)
EP (1) EP1267883B1 (enExample)
JP (2) JP4183943B2 (enExample)
KR (1) KR100874626B1 (enExample)
CN (1) CN1241570C (enExample)
AR (1) AR030277A1 (enExample)
AT (1) ATE433754T1 (enExample)
AU (2) AU4472701A (enExample)
BR (1) BR0107544A (enExample)
CA (1) CA2404767C (enExample)
DE (1) DE60139002D1 (enExample)
MX (1) MXPA02009915A (enExample)
NZ (1) NZ521784A (enExample)
TW (1) TWI232750B (enExample)
WO (1) WO2001076593A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4183943B2 (ja) * 2000-04-06 2008-11-19 スキャンポ・アーゲー １５−ケトプロスタグランジンを含む胆汁分泌促進剤組成物
EP1420794B1 (en) 2001-08-31 2017-12-27 Sucampo AG Prostaglandin analogs as chloride channel openers
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
MXPA05006981A (es) * 2002-12-27 2005-12-14 Sucampo Ag Derivados de prostaglandinas para el tratamiento de la molestia abdominal.
CA2602812C (en) * 2005-04-12 2014-11-18 Sucampo Ag Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
US8815557B2 (en) * 2005-07-08 2014-08-26 University Of Chicago Compositions and methods for refolding of denatured proteins
AU2007223469B2 (en) * 2006-02-28 2012-06-07 Sucampo Ag Method and composition for treating chronic obstructive pulmonary disease
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
US11534404B2 (en) 2016-10-06 2022-12-27 Sucampo Ag Multilayer beads for pharmaceutical use
KR102595299B1 (ko) 2020-10-12 2023-10-26 류형준 담즙 분비 촉진 효능이 있는 식품 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58203911A (ja) * 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
JPS6327433A (ja) 1986-07-21 1988-02-05 Teijin Ltd 肝疾患治療剤
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5076569A (en) * 1989-09-15 1991-12-31 Gootter Steven M Contoured grip for exercising the hand
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
TW249226B (enExample) 1990-04-04 1995-06-11 Aderk Ueno Kk
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
JPH069404A (ja) 1992-06-23 1994-01-18 Ono Pharmaceut Co Ltd 臓器移植用薬剤
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
JP4183943B2 (ja) * 2000-04-06 2008-11-19 スキャンポ・アーゲー １５−ケトプロスタグランジンを含む胆汁分泌促進剤組成物

Also Published As

Publication number Publication date
EP1267883A2 (en) 2003-01-02
CA2404767A1 (en) 2001-10-18
EP1267883B1 (en) 2009-06-17
KR20020087123A (ko) 2002-11-21
BR0107544A (pt) 2005-01-11
MXPA02009915A (es) 2003-03-27
US20030060506A1 (en) 2003-03-27
CA2404767C (en) 2010-12-07
US20020004524A1 (en) 2002-01-10
WO2001076593A3 (en) 2002-07-11
JP2004519412A (ja) 2004-07-02
DE60139002D1 (de) 2009-07-30
US6469062B2 (en) 2002-10-22
KR100874626B1 (ko) 2008-12-17
AU2001244727B2 (en) 2006-08-10
JP4183943B2 (ja) 2008-11-19
ATE433754T1 (de) 2009-07-15
AU4472701A (en) 2001-10-23
JP5073588B2 (ja) 2012-11-14
JP2008291033A (ja) 2008-12-04
CN1450899A (zh) 2003-10-22
NZ521784A (en) 2005-04-29
WO2001076593A2 (en) 2001-10-18
AR030277A1 (es) 2003-08-20
TWI232750B (en) 2005-05-21

Similar Documents

Publication Publication Date Title
JP5073588B2 (ja) １５−ケトプロスタグランジンを含む胆汁分泌促進剤組成物
EP2329825B1 (en) Method and composition for treating peripheral vascular diseases
US20100298424A1 (en) Method for treating abdominal discomfort
JP5427029B2 (ja) 消化管の重炭酸分泌を促進するための方法および組成物
CN1206997C (zh) 内皮缩血管肽拮抗剂
JP5294559B2 (ja) クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物
CN1273140C (zh) 导泻组合物
AU2001244727A2 (en) Bile secretion promoting composition
AU2001244727A1 (en) Bile secretion promoting composition
AU2001239551B2 (en) Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
KR101166739B1 (ko) 약학 조성물
JP2609479B2 (ja) カリウム排泄剤
JP2004521960A (ja) 高眼圧症および緑内障の処置のための方法および組成物
JPWO1999018968A1 (ja) 門脈圧亢進抑制剤
CN102448463A (zh) 用于调节紧密连接蛋白介导的功能和治疗皮肤病的包含前列腺素衍生物的药物组合物
JPH089544B2 (ja) 腸内排泄剤
JPH085794B2 (ja) 高脂質血症処置・血中脂質成分低下剤
HK1159501B (en) Pharmaceutical composition comprising a prostaglandin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060215

Termination date: 20150405

EXPY Termination of patent right or utility model